Jihad Tayara
CEO, Digital Transformation Leader, EvoTech
Rami Habbal
CEO, GS1
Hatem Elbehairy
RA manager, Lea Pharma
Dr. Nadia Younis
Managing Director, Stellar Pharma Consult
Jeffrey Kemprecos
Director Communications, Government Affairs & Market Access, GSK-Gulf
Sylvie Meillerais
Sylvie Meillerais started her career in research, in academia and industry, and moved to regulatory policy through positions in Brussels pharmaceutical trade associations, including EFPIA. She then joined MSD as Director Global Regulatory Policy in June 2015; in her current role, her expertise and knowledge of the European pharmaceutical environment serves to drive regulatory policy activities in the areas of CMC and Quality in the EU and globally. She is an active member of the EFPIA Manufacturing and Quality Experts Group and of the Middle East network, where she leads the Life Cycle Management efforts. She is further engaged in IFPMA CMC & Quality policy activities.
Sylvie is a French national and graduated from the University of Bordeaux II with a Maîtrise in Biochemistry and Microbiology in 1993, completed by a Diploma from the University of Kent at Canterbury in the UK (Erasmus programme).
Sylvie can be followed on linkedin.
Sylvie Meillerais
Director of Global CMC Policy, MSD Europe Inc. , Brussels
Michael Faust
RCC Business Consultant, Extedo
Dr. Mona Al Moussli
Managing Director, PRA Consultancy, UAE
Qutaiba Al Manaseer
Qutaiba Al Manaseer, is a Public affairs professional drawing on more than 15 years’ experience in the biopharmaceutical industry. He is the Government Affairs Director for the Middle East and Africa, and he is leading the COVID vaccine supply project in AstraZeneca in this region.
Qutaiba serves in the Emirates Health Economics Society board as the Media and Public Relations Chairman.
Qutaiba holds an MBA from the Swiss Business School, Switzerland and a bachelor’s degree in Pharmacy from the University of Jordan. He is completing a master’s in health economics from Barcelona School of Management.
Before joining AZ, Qutaiba was the strategic market access and pricing lead for GSK Gulf.
Qutaiba is a strong advocate for Diversity and Inclusion, and he was the Global Development Lead in the Executive committee of the Women Leadership Initiative in GSK.
Qutaiba Al Manaseer
Government Affairs Director, Middle East & Africa at AstraZeneca, AstraZeneca
Ahmad Farag
A Pharmacist with 15 years of experience in regulatory affairs & compliance in large multinational & local companies for the Middle East and Africa in many therapeutic areas like Anti-infective, Inflammation & Immunology, Oncology, CV, CNS, Urology and Women’s health products, I have also worked on different types of products like for Innovative & generic products with a particular focus on Biosimilars, besides I have experience in other different fields of the pharmaceutical industry (e.g. Quality Assurance, Quality control, Sales, Marketing, and Market access), I am a certified RAPS RegEx Pro & I have obtained a Master degree in Quality Management and a bachelor degree in pharmaceutical science.
Ahmad Farag
Regulatory Affairs Hub Team Lead (Biosimilars), AfME / RAPS RegEx Pro certified, Pfizer, Egypt
Dina Hussein Fathy
Dina holds a Bachelor of Pharmacy – Faculty of Pharmacy – Cairo university , MBA Maastricht school University-The Netherlands.
She have extensive knowledge and experience in Pharma industry and Health sector, regulatory affairs, governmental affairs for 23 years.
She also spent 10 years working with Ministry of Health in Egypt- Head of registration pharmaceutical, veterinary, Dental medical supply departments and moving to industry working with companies Sevier, MSD.
As a government official, it allows to encounter, deal with lot of different HA, Ministries e.g. ministry of foreign affairs, associations across different countries in ME, Africa. She also was Heading regulatory operations in Egypt, Libya, Saudi Arabia, year 2015- MSD.
In 2016 until date she is heading Gulf region Regulatory operations -MSD Gulf.
She is also the local Chair for the Regulatory Working group in Gulf Region and an active member in Regulatory working group for Pharma Middle East and Africa.
Dina Hussein Fathy
Regulatory Affairs Director-Gulf at Merck/MSD, Merck MSD
Dr. Yousra Farid
Yousra a Regulatory Affairs and Commercial & Distribution Quality Assurance Head with over 16 years of diversified experience from various leadership positions in regulatory affairs and Quality assurance within Health Authority as well as multinational organizations at both regional and local levels.
Yousra is currently Abbott-Gulf & Emerging. In her role in Abbott EPD, Yousra is responsible for setting Regulatory Strategies for New Product Introduction, Geo-expansion, Licensing & Acquisition, Life cycle management, enhancement of promotional model, as well as RA risk mitigation and regulatory compliance.
Yousra has set effective regulatory strategies of external engagement including Health authorities, local distributors, trade associations and Third-Party Manufacturers. This is in addition to her Quality Assurance responsibilities of establishing and embedding Quality Management System within GEM. Institute of Technology, USA which upgraded her strategic thinking and enhanced her development.
Yousra is holding a bachelor of Pharmaceutical sciences from Cairo University and RAPS-DPC certification/USA-UAE and She has also completed the “New Leadership Program (NLP)”, by Harvard Business School and is currently enrolled in “Professional Diploma in Business Planning and Strategy”, by Rochester Institute of Technology, USA.
Dr. Yousra Farid
Abbot
Dr. May Boshaibah
Pharmacist graduated from Faculty of Pharmacy since 2005
Six Years Experience in Hospital – Kuwait Ministry of health
Head of Cosmetic Department for 2 years – Pharmaceutical & Herbal Medicines Registration & Control Administration –
Kuwait Ministry of Health
Head of Training Department from 2013 until now – Pharmaceutical & Herbal Medicines Registration & Control Administration –
Kuwait Ministry of Health
Acting Head of Pricing Department – Pharmaceutical & Herbal Medicines Registration & Control Administration – Kuwait Ministry of Health
Acting of Drug Laboratory Superintendent – Pharmaceutical & Herbal Medicines Registration & Control Administration –
Kuwait Ministry of Health Registration and Release Superintendent since 2019 – Pharmaceutical & Herbal Medicines Registration & Control Administration –
Kuwait Ministry of Health
Dr. May Boshaibah
Registration & Release Superintendent, Pharmaceutical & Herbal Medicines, Registration & Control Administration Ministry of Health, Kuwait
Donia Bastakia
Ph. Donia Al Bastaki is the head of drug registration department with more than 16 years working experience in the pharmaceutical field, her area of expertise is regulatory affairs and pharmacovigilance where she contributed to the development of drug regulatory framework in Kuwait and GCC.
13 years’ experience in GMP inspection through which she inspected several international, regional and local pharmaceutical manufacturing companies .
Member of GHC Central Registration Committee since year 2007 till 2018 and contributed to setting the GCC Guidelines for Drug Registration as well as Stability, Bioequivalence and PIL GCC guidelines and others.
Member of the International Society of Pharmacovigilance and Kuwait deputy focal point for Uppsala Monitoring Center /WHO Collaborating Center for International Drug Monitoring .
She was assigned as Kuwait focal point with the League of Arab states in the field of Pharmacy and drugs and participated in the development of the Arab common Bioequivalence Guidelines
Donia Bastakia
Head of Drug Registration Department Pharmaceutical and Herbal Medicine Registration and Control Administration Ministry of Health, Kuwait
Dr. Mona al Hammadi
Bachelor degree in pharmaceutical science and pharmaceutical manufacturing , Head of new medicine registration Unit
She is a member of registration and pricing technical committee, member of GCC medical device committee
Worked on many tasks, worked as registration application reviewer (new, renew and minor variations) , Medical device registered in GCC Council , GMP inspector and pharmacovigilance officer.
Dr. Mona al Hammadi
MOHAP, UAE
Ph. Nisreen Mohammad Nassr
Mrs Nisreen Nassr is an Omani Senior specialist pharmacist, holding a Master degree in pharmaceutical Sciences. Her research was focused on Drug Discovery. In October 2015, she was appointed as the head of registration of Pharma products in the MOH, Oman. She is a member and secretary of the Technical registration and Pricing committee in MOH Oman, Bioequivalence committee and the National committee of Pharmacovigilance. Her responsibilities include policy development regulatory affairs and capacity building.
Prior to this role and since 2002, Mrs. Nisreen handled various tasks as she was the Section of Controlled Medicines, GMP inspector, registration applications reviewer, and handled pricing. In 2007, she effectively contributed in the with WHO/HAI survey on medicines prices availability and affordability.
Ph. Nisreen Mohammad Nassr
Directorate General of Pharmaceutical Affairs and Drug Control | Ministry of Health, Oman MoH, Oman
Dr. Mariam Al Jalahma
Dr Mariam Al-Jalahma was appointed by His majesty the King of Bahrain, in 2015 as the Chief Executive Officer of the National Health Regularity Authority in the Kingdom of Bahrain. She is as a member of the supreme council of health in Bahrain, and is appointed by the prime minister as a member in Academic accreditation Committee of the supreme council for Higher education in 2016.
Previous positions:
She was holding the position of Assistant Undersecretary for Primary Care and Public Health until 2015, and was a member of the Executive Board of The Health Ministers’ Council for GCC States until 2016.
A member of the Sura Council in 2000, and a member of the National Institute for Human rights. Dr. Al-Jalahma worked as an advisor for the world health organization in the fields of Adolescents and Non communicable diseases (NCDs).
Qualifications:· Arab Board certificate in Family & Community Medicine in 1990
· Higher studies diploma in medical education from Dundee University in Scotland in 1994
· Diploma in Health Care Management from Royal college of surgeon in Ireland in 2000
Honorees & medals
· In December 2011 she was awarded an honouree medal of efficiency by his majesty the king of Bahrain.
· In 1990 Awarded by the prime minister awards for leaders of Moharraq.
· In 2009 she was awarded by Her Highness Shaikha Sabika Bent Ebrahim Al-Khalifa the Princess of Bahrain and Chairperson of Woman Supreme council the award of National Woman day Celebration, the award is presented to women leaders in health.
· In June 2011 she is awarded by the regional office for eastern Mediterranean of the WHO the Anti-tobacco award of the region.
· Global award for health pioneers from UAE
· GCC leaders Award 2019
Dr. Mariam Al Jalahma
CEO National Health Regulatory Authority, Bahrain
Dr. Mohamed Hani
An experienced professional with in depth knowledge in different regulatory fields related to product regulations that include Medical devices , pharmaceuticals, Biologicals , herbal products, nutritional products, medicated cosmetics and other related product classes (FMCG), A member of multiple technical and policy making teams on a national & regional scale ,most of these teams are joint groups with different authorities from all across the UAE/ GCC like ESMA/HAAD/DHA/ DM / GCC Health Council. Has a wide experience in different areas as regulatory affairs / market access / regulatory compliance and government affairs in the GCC & MENA regions.
Dr. Mohamed Hani
Head of Conventional Drugs / Medical Devices & Complementary Medicines Registration Drug Department (UAE) , MOHAP, UAE
H. E. Dr Amin Hussain Al Amiri
His Excellency Dr. Amin Hussain Al Amiri is the Asst. Undersecretary of Public Health Policy & Licensing Sector in UAE Ministry of Health & Prevention
Dr. Al Amiri got his Ph.D. and Ms. C. in Medical Science in 2003 from Faculty of Medicine; Aberdeen University in Scotland; UK.
He is responsible for the following departments at MOHAP:• Drug Dept.
• Empowerment & Health Compliance Dept.
• Organization, Licenses& Advertisement Dept.
• Public Health Policies Dept.
H. E. Dr Amin Hussain Al Amiri
UAE Assistant Undersecretary of Public Health Policy and Licensing Sector, U.A.E Ministry of Health & Prevention ( MOHAP ), UAE
Powered By
Organized By
We accept
